SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report: November 1, 1998
Express Scripts, Inc.
- -------------------------------------------------------------------------------
(Exact Name of Registrant as specified in its Charter)
Delaware 0-20199 43-1420563
- -------------------------------------------------------------------------------
(State or other jurisdiction (Commission File No.) (I.R.S. Employer
of corporation) Identification No.)
14000 Riverport Drive, Maryland Heights, Missouri 63043
- ------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (314) 770-1666
-------------------------
- -------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On November 1, 1998, Express Scripts, Inc. issued a press release, a copy
of which is attached hereto as Exhibit 99.1, and incorporated herein by
reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(c) The following exhibit is filed as part of this report on Form 8-K:
Exhibit 99.1 Press release, November 1, 1998, by Express Scripts, Inc.
<PAGE>
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EXPRESS SCRIPTS, INC.
Date: November 13, 1998 By: /s/ Barrett A. Toan
Barrett A. Toan
President and Chief Executive Officer
<PAGE>
EXHIBIT INDEX
EXHIBIT NO. DESCRIPTION
99.1 Press release, dated November 1, 1998, by Express Scripts, Inc.
EXHIBIT 99.1
EXPRESS SCRIPTS, INC. COMPLETES 2-FOR-1 STOCK SPLIT
ST. LOUIS, November 1, 1998--Express Scripts, Inc. (NASD: ESRX) announced
today that the previously disclosed two-for-one stock split of its Class A and
Class B common stock was effective at the close of trading Oct. 30. The stock
closed at a pre-split price of 97.69. The Class A common stock will commence
trading on a post-split basis when the market opens on Monday, Nov. 2.
The stock split was for shareholders of record as of Oct. 20, 1998. The
split comes in the form of a stock dividend by issuance of one additional share
of Class A common stock for each share of Class A common stock outstanding, and
one additional share of Class B common stock for each share of Class B common
stock outstanding.
Express Scripts, Inc. is a leading specialty managed care company and
believes it is the largest independent full-service pharmacy benefit management
(PBM) company in North America. Following its acquisition of ValueRx, the
company serves thousands of clients, including managed care organizations,
insurance carriers, third-party administrators, employers and union-sponsored
benefit plans. Together, Express Scripts and ValueRx manage more than $4.0
billion in annual drug spend. The company provides a full range of consultative
PBM services, including pharmacy network management, mail service, formulary
management, disease management and medical and drug data analysis services. The
company also provides medical information management services, which include
provider profiling and outcomes assessments, informed decision counseling
services and infusion therapy services. Express Scripts is headquartered in St.
Louis, and has additional major sites in Minneapolis; Bensalem, PA; Albuquerque,
NM; Tempe, AZ; Troy, NY; and Farmington Hills, MI. More information can be found
at http://www.express-scripts.com.
